BioSpace News Archive

Drug Development

Aurinia’s Voclosporin for Kidney Disease Caused by Lupus Hits Mark in Phase III

“This extraordinary pivotal data confirms voclosporin’s ability to achieve statistically significant improvements in clinically meaningful endpoints for this complex disease, with a comparable safety profile to the current standard of care,” said Neil Solomons, Aurinia’s chief medical officer.

December 5, 2019
·
2 min read
·
Mark Terry
Biotech Beach

Research Roundup: Metformin and Healthy Aging and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

December 5, 2019
·
4 min read
·
Mark Terry
Genetown

CARB-X Supports Vedanta Biosciences Multi-Drug Resistant Asset with $5.8 Million Grant

Vedanta’s VE707 microbiome program, which is still in the preclinical stage, is designed to restore healthy microbiota and prevent infection and colonization recurrence by multi-drug-resistant superbugs.

December 5, 2019
·
2 min read
·
Alex Keown
Career Advice

Demystifying Interview Questions: “Tell Me About Yourself”

While many job seekers are unnerved by the “Tell me about yourself” request, it’s actually an opportunity to shine and take control of the interview.

December 5, 2019
·
4 min read
·
Katharine Hansen, PhD
BioCapital

Research in sheep suggests possible early test for fetal heart health

Changes in heart rate, due to low oxygen conditions, experienced by the fetus during pregnancy, could be used to predict the future heart health of babies, shows research published in The Journal of Physiology.

December 5, 2019
·
2 min read
Blood-brain barrier breakdown leads to increased activation of immune system

Scientists have found that faults in the blood-brain barrier lead to increased immune activity in the brain of mice. The researchers published the findings in two scientific papers in Science Translational Medicine.

December 5, 2019
·
2 min read
Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

Eisai Co., Ltd. announced that the latest information on its in-house discovered and developed eribulin mesylate will be presented during the 42nd San Antonio Breast Cancer Symposium.

December 5, 2019
·
1 min read
Deals

Hummingbird Bioscience raises US$19 million in Series B financing

Fundraising will support the expansion of Hummingbird Bioscience’s discovery pipeline and rapid development of its portfolio of targeted antibody therapeutics

December 5, 2019
·
3 min read
New hope for brain tumor patients in Saxony: Paracelsus Clinic Zwickau and MagForce AG open new NanoTherm therapy center for the East German region

Use of innovative technology in the treatment of brain tumor patients, now also in Zwickau, the central treatment center in East Germany.

December 5, 2019
·
3 min read
Business

MC Services is Media Partner for Biotech ShowcaseTM 2020

MC Services AG, a leading international public relations and investor relations firm, announced today that it will be, for the first time, a media partner for Biotech ShowcaseTM.

December 5, 2019
·
2 min read